Paradise Genomics, Inc. is a biotechnology company that aims to revolutionize diagnostics with their unparalleled accuracy. Founded in 2012, the Northbrook, Illinois-based company specializes in discovering gene expression bioprofiles in whole blood or tissue to diagnose various diseases. With a focus on the Biotechnology and Health Care industries, Paradise Genomics secured a $650.00K Seed Round investment on 03 January 2014. This funding injection is crucial for the company's continued growth and technology development. As the demand for advanced diagnostic solutions continues to rise, Paradise Genomics is well-positioned to make a significant impact in the healthcare sector.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Seed Round | $650.00K | - | 03 Jan 2014 |
No recent news or press coverage available for Paradise Genomics, Inc..